Role of Ultrasound Imaging in the Prediction of TRIM67 in Brain Metastases From Breast Cancer

Abstract

ObjectivesUltrasound (US) imaging is a relatively novel strategy to monitor the activity of the blood–brain barrier, which can facilitate the diagnosis and treatment of neurovascular-related metastatic tumors. The purpose of this study was to investigate the clinical significance of applying a combination of US imaging outcomes and the associated genes. This was performed to construct line drawings to facilitate the prediction of brain metastases arising from breast cancer.MethodsThe RNA transcript data from The Cancer Genome Atlas (TCGA) database was obtained for breast cancer, and the differentially expressed genes (DEGs) associated with tumor and brain tumor metastases were identified. Subsequently, key genes associated with survival prognosis were subsequently identified from the DEGs.ResultsTripartite motif-containing protein 67 (TRIM67) was identified and the differential; in addition, the survival analyses of the TCGA database revealed that it was associated with brain tumor metastases and overall survival prognosis. Applying independent clinical cohort data, US-related features (microcalcification and lymph node metastasis) were associated with breast cancer tumor metastasis. Furthermore, ultrasonographic findings of microcalcifications showed correlations with TRIM67 expression. The study results revealed that six variables [stage, TRIM67, tumor size, regional lymph node staging (N), age, and HER2 status] were suitable predictors of tumor metastasis by applying support vector machine–recursive feature elimination. Among these, US-predicted tumor size correlated with tumor size classification, whereas US-predicted lymph node metastasis correlated with tumor N classification. The TRIM67 upregulation was accompanied by upregulation of the integrated breast cancer pathway; however, it leads to the downregulation of the miRNA targets in ECM and membrane receptors and the miRNAs involved in DNA damage response pathways.ConclusionsThe TRIM67 is a risk factor associated with brain metastases from breast cancer and it is considered a prognostic survival factor. The nomogram constructed from six variables—stage, TRIM67, tumor size, N, age, HER2 status—is an appropriate predictor to estimate the occurrence of breast cancer metastasis.

Prevention of polycystic ovary syndrome and postmenopausal osteoporosis by inhibiting apoptosis with Shenling Baizhu powder compound

“…TRIzol (Sangon, Shanghai, China) was used to obtain RNA from the osteoblast cell line and ovarian granulosa cell line treated above according to the manufacturer’s instructions as previous researches ( Rio et al, 2010 ; Ma et al, 2022 ; Xuan et al, 2022 ). The obtained RNA was reverse transcribed into cDNA using GoScript ™ Reverse Transcription Kit (Promega, Madison, WI, SA), and the mRNA expression level was subsequently determined using FastFire qPCR PreMix (SYBR Green) (Tiangen, Beijing, China).…”

Machine learning for infection risk prediction in postoperative patients with non-mechanical ventilation and intravenous neurotargeted drugs

“…Root Mean Squard Error (RMSE) metrics were applied to evaluate the accuracy of the SVM models and to determine the best model variables based on the RMSE minimum. Furthermore, neural networks, a common non-linear algorithmic model in machine learning, were also used to evaluate results as previous researches (34)(35)(36)(37)(38).…”

Prognostic microRNAs associated with phosphoserine aminotransferase 1 in gastric cancer as markers of bone metastasis

“…The microRNAs obtained above were calculated as the expression between gastric cancer tissues and normal tissues, and the microRNAs with statistically significant differences in expression were screened by the p < 0.05. Survival curves were plotted by Kaplan-Meier method based on the median expression value of each microRNA as previous researches (Rich et al, 2010;Lacny et al, 2015;Sun et al, 2022;Xuan et al, 2022).…”